Q32 Bio Inc.(FIXX)— Stock Profile, AI Score & Financials

Healthcare · Nasdaq · AI-powered stock analysis, 32-signal quality score, SEC EDGAR financials, and institutional holdings. Updated 2026-06-30.

Q32 Bio Inc. (FIXX) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro's AI-powered ranking engine scores FIXX at 36.4/100 on a 32-signal composite quality model, placing it at rank #2,279 of 3,064 stocks — the bottom half of the AI-ranked universe. FIXX scores in the top quartile across balance sheet strength (96.3), institutional flow (92.5). Areas of concern include earnings quality (3.9) and revenue growth (30.0), which score below median versus the broader universe. Shareholder dilution risk is elevated at 15.9/100, reflecting ongoing share issuance or stock-based compensation. Top institutional holders of FIXX by reported 13-F value include ORBIMED ADVISORS, Boxer Capital Management, Atlas Venture Life Science Advisors, based on the most recent SEC filings. FIXX trades on the Nasdaq exchange and files with the SEC under CIK 1661998. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate FIXX daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Q32 Bio Inc. directly from SEC EDGAR.